Orphan drug spending growth characteristics in the U.S. 2012-2017
This statistic depicts characteristics of the U.S. orphan drug market growth between 2012 and 2017. In that period, the sales of drugs costing more or equal to 6,000 U.S. dollars per year amounted to 18.2 billion dollars in growth.